T.Man Pharmaceutical PCL (BKK:TMAN)

Market Cap	4.92B
Revenue (ttm)	2.25B
Net Income (ttm)	440.99M
Shares Out	400.00M
EPS (ttm)	1.16
PE Ratio	10.58
Forward PE	10.04
Dividend	0.20 (1.63%)
Ex-Dividend Date	Aug 26, 2025

Volume	346,938
Average Volume	163,476
Open	12.30
Previous Close	12.30
Day's Range	12.10 - 12.30
52-Week Range	9.90 - 19.30
Beta	n/a
RSI	59.85
Earnings Date	Aug 13, 2025

About T.Man Pharmaceutical PCL

T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1991
• Employees: 824
• Stock Exchange: Stock Exchange of Thailand
• Ticker Symbol: TMAN

Financial Performance

In 2024, T.Man Pharmaceutical PCL's revenue was 2.23 billion, an increase of 12.42% compared to the previous year's 1.98 billion. Earnings were 450.70 million, an increase of 4.55%.